´ëÇѺñ¸¸ÇÐȸ ICOMES 2021 (2ÀÏÂ÷) : 2021-09-03±³À°ÀÏÀÚ : 2021-09-03
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ (*¿ÀÇÁ¶óÀÎ: ¿©Àǵµ ÄÜ·¡µå È£ÅÚ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) ICOMES 2021 (2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ
´ã´çÀÚ : °¶ó¿µ
¿¬¶ôó : 02-6941-0888
À̸ÞÀÏ :
obesity@kosso.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 31 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 07:30~08:00 The Renoprotective of Effect and Safety of Gemigliptin for Type 2 Diabetes Jun Hwa Hong(È«ÁØÈ)(Eulji University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 07:30~08:00 The Korean Titration Study: Simple & Easy Titration Method for Glargine 300 Young Min Cho(Á¶¿µ¹Î)(Seoul National University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 1,2,3, 5F 08:15~08:55 Efficacy and Safety of Semaglutide in Japanese and Korean: STEP6 Study Takashi Kadowaki(The University of Tokyo Hospital, Japan)
ÈÞ½Ä 09-03 08:55~09:00 ÈÞ½Ä ()
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 09:00~09:30 Kartell of Death: Visceral Obesity and Cardiovascular Disease Carl (Chip) J. Lavie(Louisiana State University, USA)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 09:30~10:00 Cardiovascular Risk: Variability Matters Kyung Mook Choi(Ãְ湬)(Korea University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 10:00~10:30 CV Risk in Metabolically Healthy Obesity Changhee Jung(Á¤Ã¢Èñ)(University of Ulsan, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 09:00~09:30 Roles of Gut Microbes In The Pathogenesis and Development of Obesity, NAFLD, and Diabetes: A Systems Perspective Hao Wu(Fudan University, China)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 09:30~10:00 Which Option is More Suitable after the Dual Therapy for Korean T2DM Patients?: Sun Jae Lee (À̼±Àç)(Gwangju Institute of Science and Technology, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 10:00~10:30 Microbiome and Metabolic Diseases Gwangpyo Ko(°í±¤Ç¥)(Seoul National University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 09:00~09:30 The Role of The Hypothalamic Cereblon (CRBN) in The Control of Feeding Behavior and Body Weight Jaemin Lee(ÀÌÀç¹Î)(DGIST, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 09:30~10:00 Long-term Increase of AgRP Neuron Activity Causes Body Weight Gain without Affecting Food Intake Jong-Woo Sohn(¼ÕÁ¾¿ì)(KAIST, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 10:00~10:30 Algorithms for Appetite Scott Sternson(UCSD, USA)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 09:00~09:30 Socioeconomic Inequalities of Obesity in Australia Mark Harris(University of New South Wales, Australia)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 09:30~10:00 Socioeconomic Inequalities of Obesity in Taiwan Wen-Harn Pan(Institute of Biomedical Sciences Academia Sinica Taipei, Taiwan)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 10:00~10:30 Trends in Socioeconomic Inequalities in Major Risk Factors for Cardiovascular Disease in Korea Sin-Gon Kim(±è½Å°ï)(Korea University, Korea)
±³À°½Ã°£ 09-03 Studio 4, 6F 09:00~09:35 Keep Your Confidence on Type 2 DM in Broad Range of Patients So Hun Kim(±è¼ÒÇå)(Inha University, Korea)
±³À°½Ã°£ 09-03 Studio 4, 6F 09:35~10:10 The Latest Evidence of SGLT2 Inhibitors for Patients with Type 2 Diabetes Suk Chon(Àü¼÷)(Kyung Hee University, Korea)
±³À°½Ã°£ 09-03 Studio 4, 6F 10:10~10:30 Discussion So Hun Kim(±è¼ÒÇå) / Suk Chon(Àü¼÷)(Inha University, Korea / Kyung Hee University, Korea)
ÈÞ½Ä 09-03 10:30~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 09-03 Park Ballroom 1,2,3, 5F 10:45~11:25 Implication of Obesity in Cardiometabolic Risk Robert H. Eckel(University of Cololado Anschutz Medical Center, USA)
ÈÞ½Ä 09-03 11:25~11:30 ÈÞ½Ä ()
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 11:30~12:30 Oral Presentation 1 ()
±³À°½Ã°£ 09-03 Studio 4, 6F 11:30~12:30 Oral Presentation 2 ()
ÈÞ½Ä 09-03 12:30~12:40 ÈÞ½Ä ()
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 12:40~13:40 Long-Term Efficacy & Safety on Combination Phentermine Plus Topiramate ER: Where Do We Stand? Tae Jung Oh(¿ÀÅÂÁ¤)(Seoul National University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 12:40~13:40 Individualized T2DM Treatment Focus on Recent Treatment Option Jae Hyuk Lee(ÀÌÀçÇõ)(Hanyang University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 12:40~13:40 Glycemic Control for Reversing Diabesity Ji-Won Lee(ÀÌÁö¿ø)(Yonsei University, Korea)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 12:40~13:40 Long-Term Efficacy & Safety on Combination Phentermine Plus Topiramate ER : Where Do We Stand? Tae Jung Oh(¿ÀÅÂÁ¤)(Seoul National University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 13:40~14:10 Role of Amylin Analogues in Obesity Management Carel le Roux(University College Dublin, Ireland)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 14:10~14:40 Obesity Control with SGLT2i and GLP1RA Combination Therapy Jun Hwa Hong(È«ÁØÈ)(Eulji University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 14:40~15:10 Patient-Centered Anti-Obesity Medication Sang Yeoup Lee(ÀÌ»ó¿±)(Pusan University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 13:40~14:10 Telenutrition for managing obesity and metabolic diseases Rani Polak(Institute of Lifestyle Medicine)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 14:10~14:40 A New Paradigm for Clinical Nutrition Services in The Era of The Fourth Industrial Revolution Jung-Sook Seo(¼Á¤¼÷)(Yeungnam University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 13:40~14:10 Dissecting The Risk Factor of Severe COVID-19 Patients with Obesity and Metabolic Disorders Jae-Han Jeon(ÀüÀçÇÑ)(Kyungpook National University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 14:10~14:40 Management of Obesity-Lessons Learnt from COVID-19 Alice Pik Shan Kong(The Chinese University of Hong Kong, Hong Kong)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 14:40~15:10 COVID-19 Vaccination and Obesity Won Suk Choi(ÃÖ¿ø¼®)(Korea University, Korea)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 13:40~14:10 Endoscopic Bariatrics Silvana Perretta(Research Institute against Digestive Cancer IRCAD, France)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 14:10~14:40 Prediction Model for Chronological Weight Loss after Bariatric Surgery in Korean Patients Ji Yeon Park(¹ÚÁö¿¬)(Kyungpook National University, Korea)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 14:40~15:10 Diabetes Remission after Sleeve Plus Procedure in Korean Patients Yong Jin Kim(±è¿ëÁø)(H Plus Yangji Hospital, Korea)
±³À°½Ã°£ 09-03 Studio 4, 6F 13:40~14:10 The Efficacy & Safety of Combination Phentermine Plus Topiramate ER for Obese Patients with Hypertension and Hyperlipidemia Hyuk Tae Kwon(±ÇÇõÅÂ)(Seoul National University, Korea)
±³À°½Ã°£ 09-03 Studio 4, 6F 14:10~14:40 The Efficacy and Safety of Combination Phentermine Plus Topiramate ER for Obese Patients with Type 2 Diabetes Mellitus Won Jin Kim(±è¿øÁø)(CHA Medical Center, Korea)
±³À°½Ã°£ 09-03 Studio 4, 6F 14:40~15:10 The Benefits of Prescribing Combination Phentermine Plus Topiramate ER for Obese Patients from The Clinician¡¯s Perspective ±è¼±Çü(Áö¼¼ºìÀÇ¿ø)
ÈÞ½Ä 09-03 15:10~15:30 ÈÞ½Ä ()
±³À°½Ã°£ 09-03 Park Ballroom 1,2,3, 5F 15:30~16:10 Role of GLP1 Analogues and Other Gut Hormones in Obesity Management John Wilding(University of Liverpool, UK)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 16:10~16:40 Role of NAFLD in Metabolically Healthy and Unhealthy Obesity Norbert Stefan(University Hospital of Tubingen, Germany)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 16:40~17:10 Current Status and Future Trends in NASH Therapeutics Yong-ho Lee(ÀÌ¿ëÈ£)(Yonsei University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 1, 5F 17:10~17:40 How Does Obesity Affect Cancer Incidence and Mortality? Hae-Jin Ko(°íÇýÁø)(Kyungpook National University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 16:10~16:40 Importance of Body Composition in Obesity Management Steven Heymsfield(Pennington Biomedical Research Center Louisiana State University, USA)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 16:40~17:10 Muscle Matters in Older Men and Fat Matters in Older Women Chang Won Won(¿øÀå¿ø)(Kyung Hee University, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 2, 5F 17:10~17:40 Sarcopenia in Asia Liang-Kung Chen(Taipei Municipal Gan-Dau Hospital, Taiwan / National Yang Ming Chiao Tung University, Taiwan)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 16:10~16:40 Collateral Health Impact of Containing COVID-19 in Children Young June Choe(ÃÖ¿µÁØ)(Korea University Anam Hospital, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 16:40~17:10 Impact of COVID-19 on Pediatric Obesity and Comorbidities Moonbae Ahn(¾È¹®¹è)(The Catholic University of Korea, Korea)
±³À°½Ã°£ 09-03 Park Ballroom 3, 5F 17:10~17:40 COVID-19 and Its Impact on Childhood Obesity Pik To Cheung(Virtus Medical Group, Hong Kong)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 16:10~16:30 Obesity, The Official Journal of The Obesity Society Donna H.Ryan(Pennington Biomedical Research Center, USA)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 16:30~16:50 International Journal of Obesity Nikhil V. Dhurandhar(Texas Tech University, USA)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 16:50~17:10 Obesity Research & Clinical Practice Gary Wittert(University of Adelaide, Australia)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 17:10~17:25 Past, present and future of JOMES Eun-Jung Rhee(ÀÌÀºÁ¤)(Sungkyunkwan University, Korea)
±³À°½Ã°£ 09-03 Studio 1+2+3, 6F 17:25~17:40 Panel Discussion Bokyung Koo(±¸º¸°æ) / Changhee Jung(Á¤Ã¢Èñ)(Seoul National University, Korea / University of Ulsan, Korea)
±³À°½Ã°£ 09-03 Studio 4, 6F 16:10~16:40 Evidence Based Choice for Effective and Safe Obesity Therapeutics Jamy Ard(Wake Forest School of Medicine, USA)
±³À°½Ã°£ 09-03 Studio 4, 6F 16:40~17:10 Connecting Research to Clinical Implications with GLP-1RAs Lotte Bjerre Knudsen(Novo Nordisk A/S, Denmark)
±³À°½Ã°£ 09-03 Studio 4, 6F 17:10~17:40 Role of GLP-1RA on Visceral Obesity and Cardiometabolic Risk Factors Jee-Hyun Kang(°ÁöÇö)(Konyang University, Korea)